GENE ONLINE|News &
Manufacturing & Logistics
BioJapan 2026 Opens at 40 as Japan Links ¥1.1 Trillion in Biotech Investment With AI, Manufacturing and Global Partnerships
2026-10-08
Japan Turns to Domestic Capacity and Taiwan Partnerships to Reduce Pharmaceutical Supply Risk
2026-10-07
From “Just-in-Time” to “Just-in-Case”: Rewiring the Global Pharma Supply Chain for Ultimate Resilience
2026-07-21
Can Global Healthcare Systems Stay Resilient Without Reinventing Pharmaceutical Manufacturing?
2026-05-20
EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan
2026-04-28
Navigating the 2030 Horizon: Japan’s CPHI Brings the Regulatory Evolution and Rise of the Triple-Helix Ecosystem
2026-04-21
[Illustrations] 2026 Policy and Geopolitics as Catalysts: IRA Pricing Mechanics and BIOSECURE’s Supply Chain Decoupling
2026-02-09
Indian Generics Gain Ground in China as the Global Procurement Landscape Demands a New Industrial Model
2025-11-13
The Biologics Landscape Is Changing—Fast: CDMOs Race to Integrate Development, Scale, and Next-Gen Modalities
2025-10-20
Strategic Outsourcing: How CDMO Partnerships Are Tipping the Scales from Cost Efficiency to Supply Chain Resilience
2025-10-20
LATEST
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
